Literature DB >> 7424822

Yersinia enterocolitica Septicemia.

E Bouza, A Dominguez, M Meseguer, L Buzon, D Boixeda, M J Revillo, L de Rafael, J Martinez-Beltran.   

Abstract

Human Yersinia enterocolitica septicemia is an uncommon condition. Four new cases are reported here and a review is made of 51 others taken from medical literature. Septicemia caused by this microorganism occurs more frequently in the young and in the elderly, and usually involves patients havig previous liver or blood disorders, diabetes mellitus, and other debilitating diseases. Clinically it is indistinguishable from sepsis caused by other organisms of Enterobacteriaceae, but it is important that the clinician bear its existence in mind, since Yersinia enterocolitica strains are usually resistant to beta-lactam antibiotics, whereas they are susceptible to the aminoglycosides and co-trimoxazole, among others. Susceptibilities in the blood isolates from our patients, and in another ten fecal isolates from eight other patients showed the previously described pattern. Our isolates, however, were all susceptible to the new cephalosporins, cefamandole and cefoxitin, and to the experimental ones, HR-756, T-1551, and Ly-127.935.

Entities:  

Mesh:

Year:  1980        PMID: 7424822     DOI: 10.1093/ajcp/74.4.404

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  24 in total

Review 1.  Yersinia enterocolitica in donor blood: a case report and review.

Authors:  J Jacobs; D Jamaer; J Vandeven; M Wouters; C Vermylen; J Vandepitte
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

Review 2.  Liver abscess due to Yersinia enterocolitica: case report and review of the literature.

Authors:  R Khanna; H Levendoglu
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

3.  Characterization of a novel porin involved in systemic Yersinia enterocolitica infection.

Authors:  Shirly Mildiner-Earley; Virginia L Miller
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 4.  The critical role of iron in some clinical infections.

Authors:  J J Bullen; C G Ward; H J Rogers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-08       Impact factor: 3.267

5.  Yersinia enterocolitica infection with ileal perforation associated with iron overload and deferoxamine therapy.

Authors:  G Mazzoleni; D deSa; J Gately; R H Riddell
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

6.  YspM, a newly identified Ysa type III secreted protein of Yersinia enterocolitica.

Authors:  Sarah E Witowski; Kimberly A Walker; Virginia L Miller
Journal:  J Bacteriol       Date:  2008-09-19       Impact factor: 3.490

7.  Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica.

Authors:  Deyan Luo; Frank M Szaba; Lawrence W Kummer; Edward F Plow; Nigel Mackman; David Gailani; Stephen T Smiley
Journal:  J Immunol       Date:  2011-07-01       Impact factor: 5.422

Review 8.  Yersinia enterocolitica: the charisma continues.

Authors:  E J Bottone
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

9.  T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica.

Authors:  I B Autenrieth; A Tingle; A Reske-Kunz; J Heesemann
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Effects of iron and desferrioxamine on infections with Yersinia enterocolitica.

Authors:  R M Robins-Browne; J K Prpic
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.